Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Letrozole in Advanced or Recurrent Endometrial Cancer
NCT00333086Phase 2Completed
- Sponsor
- Novartis
- Start
- Jan 2000
- Primary completion
- Jun 2006
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of letrozole in endometrial cancer (EC), sponsored by Novartis. Started Jan 2000; status: completed.
02
Drugs
letrozole
03
Conditions
endometrial cancer (EC)
Beyond the preview
Go deeper on NCT00333086.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00333086.